National Research Corporation (NRC) vs SOPHiA GENETICS SA (SOPH)
- National Research Corporation NRC 25.83 +1.37%
- SOPHiA GENETICS SA SOPH 7.09 +7.10%
National Research Corporation and SOPHiA GENETICS SA are both Health Information Services companies. National Research Corporation and SOPHiA GENETICS SA are of similar size ($563.6M and $563.6M). SOPHiA GENETICS SA has negative trailing earnings, so its P/E is not meaningful; National Research Corporation trades at 87.6×. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 24.1% against 3.37%. National Research Corporation has the higher net margin (0.00% vs −89.2%) and the higher return on invested capital (11.6% vs −200.9%). Across the 18 metrics below, National Research Corporation leads on 11 and SOPHiA GENETICS SA on 7.
Valuation
Profitability
| Metric | NRC | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 60.69% | 66.43% | 59.61% |
| Operating margin | 11.06% | (80.99%) | (10.54%) |
| Net margin | 0.00% | (89.18%) | (16.14%) |
| Free cash flow margin | 12.83% | (45.64%) | 0.00% |
| Return on equity | 0.00% | (125.67%) | (3.15%) |
| Return on assets | 0.00% | (46.60%) | (5.62%) |
| Return on invested capital | 11.64% | (200.89%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack